A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
7 Hills Pharma, LLC
7 Hills Pharma, LLC
Obsidian Therapeutics, Inc.
Filamon LTD
Mayo Clinic
Ankyra Therapeutics, Inc
Washington University School of Medicine
University of Florida
University of Nebraska
Elephas
Elephas
Cancer Research UK
Massive Bio, Inc.
British Columbia Cancer Agency
University of Florida
Medicenna Therapeutics, Inc.
Columbia University
University of Arizona
Stanford University
Iovance Biotherapeutics, Inc.
Fondazione Policlinico Universitario Agostino Gemelli IRCCS